This website uses cookies to help us give you the best browsing experience. By continuing to use this portal, you agree to our use of this tool.
To learn more about how we use cookies and how to manage them please read our notice here.
Neuroprotection SIG
Mission

Providing a forum to facilitate the understanding and implementation of neuroprotective treatment in glaucoma, and the development of collaborative and well-designed neuroprotective clinical trials.

Action plan

  • To provide a forum for the discussion of new, interesting and controversial findings in the area
  • To promote understanding of science behind neuroprotective strategies by encouraging dialogue between glaucoma, allied clinicians and basic scientists
  • To encourage high standards of evidence-based medicine and research in the application of neuroprotection in glaucoma leading to a consensus on effective therapies
  • To disseminate the results of translational research and facilitate appropriate clinical trials
  • To update the community with the results of clinical trials & basic research in area of neuroprotection


Chair

Francesca Cordeiro
United Kingdom

Co-Chair

Miriam Kolko
Denmark
Startup Meeting   •   EGS Guidelines on NP  •   SIG Corner (June 2019)   •   Contact


back to top